Healthcare provider profile · identity verified

Savreet Kaur Singh, MD

Family Practice · JACKSON, MI · NPI 1508412891

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	486	180
Levothyroxine Sodium	Levothyroxine Sodium	395	128
Lisinopril	Lisinopril	316	108
Amlodipine Besylate	Amlodipine Besylate	311	101
Omeprazole	Omeprazole	285	93
Gabapentin	Gabapentin	246	62
Losartan Potassium	Losartan Potassium	244	87
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	239	39
Metoprolol Succinate	Metoprolol Succinate	235	79
Albuterol Sulfate Hfa	Albuterol Sulfate	194	67
Pantoprazole Sodium	Pantoprazole Sodium	158	60
Metformin Hcl	Metformin Hcl	151	48
Duloxetine Hcl	Duloxetine Hcl	144	42
Simvastatin	Simvastatin	141	47
Rosuvastatin Calcium	Rosuvastatin Calcium	140	46
Metformin Hcl Er	Metformin Hcl	139	41
Pravastatin Sodium	Pravastatin Sodium	124	48
Sertraline Hcl	Sertraline Hcl	114	38
Furosemide	Furosemide	113	36
Alprazolam	Alprazolam	112	32
Hydrochlorothiazide	Hydrochlorothiazide	108	36
Ozempic	Semaglutide	104	20
Tramadol Hcl	Tramadol Hcl	102	18
Meloxicam	Meloxicam	98	38
Mounjaro	Tirzepatide	93	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	35
Trazodone Hcl	Trazodone Hcl	91	29
Metoprolol Tartrate	Metoprolol Tartrate	88	35
Atenolol	Atenolol	87	27
Citalopram Hbr	Citalopram Hydrobromide	87	26
Famotidine	Famotidine	85	30
Montelukast Sodium	Montelukast Sodium	84	30
Potassium Chloride	Potassium Chloride	83	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	25
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	79	79
Eliquis	Apixaban	76	22
Prednisone	Prednisone	75	59
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	18
Tamsulosin Hcl	Tamsulosin Hcl	69	26
Baclofen	Baclofen	64	16
Lorazepam	Lorazepam	63	11
Buspirone Hcl	Buspirone Hcl	57	22
Carvedilol	Carvedilol	57	18
Oxybutynin Chloride Er	Oxybutynin Chloride	56	20
Jardiance	Empagliflozin	54	17
Allopurinol	Allopurinol	53	20
Pregabalin	Pregabalin	51	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	51	42
Fluoxetine Hcl	Fluoxetine Hcl	50	18
Fluticasone Propionate	Fluticasone Propionate	50	27
Januvia	Sitagliptin Phosphate	50	14
Glipizide Er	Glipizide	49	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Glimepiride	Glimepiride	44	14
Clonazepam	Clonazepam	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	13
Spironolactone	Spironolactone	43	15
Tizanidine Hcl	Tizanidine Hcl	40	13
Ibuprofen	Ibuprofen	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Spiriva Handihaler	Tiotropium Bromide	39	suppressed
Ezetimibe	Ezetimibe	38	13
Methocarbamol	Methocarbamol	38	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Mirtazapine	Mirtazapine	36	12
Ventolin Hfa	Albuterol Sulfate	36	21
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Ketoconazole	Ketoconazole	34	17
Nystatin	Nystatin	34	15
Lovastatin	Lovastatin	33	13
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	32	32
Topiramate	Topiramate	32	suppressed
Clobetasol Propionate	Clobetasol Propionate	31	25
Warfarin Sodium	Warfarin Sodium	31	suppressed
Xarelto	Rivaroxaban	31	11
Bupropion Xl	Bupropion Hcl	30	11
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Incruse Ellipta	Umeclidinium Bromide	30	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	18
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Azithromycin	Azithromycin	25	23
Doxycycline Hyclate	Doxycycline Hyclate	25	17
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Rybelsus	Semaglutide	24	11
Alendronate Sodium	Alendronate Sodium	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Estradiol	Estradiol	22	suppressed
Naproxen	Naproxen	22	11
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	12
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	20
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Tiotropium Bromide	Tiotropium Bromide	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Fluconazole	Fluconazole	17	11
Meclizine Hcl	Meclizine Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Nyamyc	Nystatin	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	11
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Glipizide	Glipizide	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Eszopiclone	Eszopiclone	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Fondaparinux Sodium	Fondaparinux Sodium	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error